Cargando…
美法仑联合大剂量地塞米松一线治疗原发性轻链型淀粉样变的疗效分析
OBJECTIVE: To evaluate the response of oral melphalan plus high-dose dexamethasone (MDex) for patients with primary light chain amyloidosis (pAL). METHODS: Clinical data, hematological and organ responses, and survival of 76 patients with pAL who had received MDex from January 2009 to July 2017 were...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342839/ https://www.ncbi.nlm.nih.gov/pubmed/30180464 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.08.006 |